New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 19, 2013
08:14 EDTNXTMNxStage Medical announces CE Mark approval for noctural home hemodialysis
NxStage Medical announced CE Mark approval for nocturnal home hemodialysis with the NxStage System One. NxStage expects to begin marketing the System One for nocturnal dialysis in countries that recognize the CE Mark approval process in the second half of 2013.
News For NXTM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 25, 2015
08:02 EDTNXTMNxStage Medical presents four positive abstracts for NxStage System One
NxStage Medical announced the presentation of four new abstracts demonstrating clinical outcomes during the National Kidney Foundation's Spring Clinical Meeting in Dallas, Texas. Three of the abstracts highlight improved survival, reduced cardiovascular hospital readmissions, and increased transplantation for daily home hemodialysis patients using the NxStage® System One versus other modalities. The fourth abstract details results from the company's study that led to the clearance of the System One as the first and only hemodialysis machine cleared for home nocturnal hemodialysis. The first three abstracts show: 29% lower risk of death for incident patients using DHHD vs. patients receiving conventional in-center hemodialysis, 15% lower risk of 30-day readmission after hospitalization for heart failure than peritoneal dialysis (PD) patients and 27% lower than IHD patients, and 37% greater incidence of transplant for DHHD patients than PD patients, and 22% greater than IHD patients.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use